Cheryl Gault, Chief Operating Officer at Rapport Therapeutics, Inc. (RAPP), sold 10,000 shares at $40.09 ($416K) on 2026-06-30, disclosed to the SEC on 2026-07-01.
Scheduled sale ($416k) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $40.09 | 1,900 | $76K | 18.3% |
| 2 | $41.39 | 3,792 | $157K | 37.8% |
| 3 | $42.17 | 3,308 | $140K | 33.6% |
| 4 | $43.15 | 1,000 | $43K | 10.4% |
| Total | $41.58 avg | 10,000 | $416K | 100% |
| Filing → |
| RAPP | SELL | 2025-12-01 | $151K | — | Filing → |
| RAPP | SELL | 2025-09-10 | $192K | — | Filing → |